Ranbaxy

Ranbaxy's peptic ulcer drug cleared for US launch

25 Aug 2009

Religare bids for ING’s Asian assets

17 Aug 2009

Ranbaxy to market cholesterol-lowering drug in Canada

21 Jul 2009

Ranbaxy's US subsidiary recalls anti-acne drug from US market

10 Jul 2009

Daiichi Sankyo to raise $3 billion in bonds to repay Ranbaxy’s acquisition loan

01 Jun 2009

Ranbaxy holds breath as FDA scrutinises corrective action plan

30 May 2009

Markets cheer Malvinder’s exit from Ranbaxy

26 May 2009

Ranbaxy acquires rights for Ochoa Labs’ skincare products

22 May 2009

Religare in race for AIG's fund management unit

12 May 2009

Ranbaxy's investment arm Religare is reported to have bid for the investment management arm of beleaguered US insurer, AIG, as part of its its financial services portfolio expansion strategy

Ranbaxy's anti-malaria molecule enters Phase III clinical trial

06 May 2009

Ranbaxy recalls Nitrofurantoin capsules in the US

02 May 2009

Aurobindo's HIV drug, Ranbaxy's epillepsy drug get USFDA nod

01 Apr 2009

Ranbaxy to launch Daiichi's hypertension drug in India

31 Mar 2009

Ranbaxy investment arm Religare hikes rights issue target

26 Mar 2009

UK, Australia okay drugs from Ranbaxy plant

24 Mar 2009

Ranbaxy's cardio drug `Ramipril' gets US FDA approval

09 Mar 2009

Ranbaxy hospital group Fortis taps outdoor opportunities

03 Mar 2009

Ranbaxy plant in India falsified data: US FDA

25 Feb 2009

Bhavdeep Singh becomes CEO of Fortis

24 Feb 2009

FDA woes hit Ranbaxy in Q4

23 Jan 2009

Ranbaxy in pact to market BioPro's brain tumour drug in India

03 Dec 2008

Daiichi Sankyo completes Ranbaxy acquisition

07 Nov 2008

Ranbaxy investment arm Religare to acquire majority stake in Lotus India AMC

04 Nov 2008

Daiichi acquires 52.5 per cent in Ranbaxy

20 Oct 2008

CNBC-TV18 shares with domain-b its exclusive interview with Ranbaxy, CEO, Malvinder Singh

Ranbaxy-Daiichi deal hits a regulatory bump

17 Oct 2008